Saving time during every stage of the drug development process is a critical factor.  Saving time can mean the difference between being first to market for a new class of drug, or for a first-to-file generic.  This is especially important during early development when important decisions have to be made between competing developmental programs.  Ascendia recognizes the value of rapid development timelines, and offers services designed to reach early-stage key milestones in your development program quickly.   Our services include pre-formulation, enabling formulations for toxicology and pharmacokinetic studies, pilot ANDA formulations, and Phase I clinical trial materials for either oral or parenteral products.

Want to learn more about
Ascendia's expertise?

Get up-to-date information

Stay in touch >